ChickenStock Research
US SEC filing analysis
Read reviewed analyses of US SEC filings in English. Each report shows the form, the filing date, the scope of the analysis and the original filing.
Stock, IR and earnings analyses are available in Korean only. Korean analysis reports →
Find a company
Search by company name, ticker or report title.
US filing forms
Includes amendments (/A).Events and earnings releases · Reports events such as earnings releases, agreements and management changes. Not every 8-K is an earnings release.
US filing analysis · 8-K
Sorted by SEC acceptance time (filing date when unavailable). Page 31 · 30 shown · up to 30 per page
JNJ
Johnson & Johnson said reported sales for Q3 2025 grew to $23,993 million, up 6.8%, net earnings were $5,152 million and diluted earnings per share were $2.12.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 14, 2025
GS
Goldman Sachs reported net revenues of $15.18 billion and net earnings of $4.10 billion for Q3 2025, with diluted earnings per common share of $12.25. Net revenues for Q3 were 20% higher than Q3 2024 and 4% higher than Q2.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 14, 2025
FAST
Fastenal said net sales for Q3 2025 were $2,133.3 million, an increase of 11.7% from $1,910.2 million in the year-ago period. Net income for the quarter was $335.5 million, and diluted net income per share was $0.29.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 14, 2025
BLK
BlackRock reported results of operations for the 3 and 9 months ended October 14, 2025 and September 30, 2025, with the earnings release attached as Exhibit 99.1.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 14, 2025
DAL
Delta said adjusted total revenue for the September 2025 quarter increased 4.1% year-over-year to a record $15.2 billion ($15,197 million) as of the September quarter. The company cited a 2.6-point benefit from lapping last year's CrowdStrike-caused outage on total revenue growth.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 9, 2025
EOG
EOG said it received net cash of $27 million from settlements of Financial Commodity Derivative Contracts during Q3 2025. There was no cash received related to the Brent Linked Gas Sales Contract.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 8, 2025
APA
APA said it received substantial payments from the Egyptian General Petroleum Corporation (EGPC) during Q3, and total distributions to its non-controlling interest partner in Egypt during Q3 were $173 million, compared to $126 million in Q1 and $91 million in Q2.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 8, 2025
STZ
For the 3 months ended August 31, Constellation reported net sales of $2,481.0 million, a 15% decrease, operating income of $874.0 million, and diluted net income per share of $2.65. In the prior-year period, operating loss was $(1,229.4) million, which included goodwill impairment of $2,250.0 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 6, 2025
ABBV
AbbVie said acquired IPR&D and milestones expense of $2.7 billion on a pre-tax basis is expected to be included in GAAP and adjusted non-GAAP results for Q3 2025, representing an unfavorable impact of $1.50 to both diluted earnings per share and adjusted non-GAAP diluted earnings per share.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 3, 2025
TSLA
Tesla said it produced 447,450 vehicles and delivered 497,099 vehicles in Q3 2025. By model, Model 3/Y had production of 435,826 and deliveries of 481,166, while Other Models had production of 11,624 and deliveries of 15,933.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 2, 2025
CTVA
Corteva announced on October 1, 2025 that its Board of Directors has unanimously approved a plan to separate the company into two independent, publicly traded companies, one comprising its current Crop Protection business ("New Corteva") and the other comprising its current Seed business ("SpinCo").
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Oct 1, 2025
NKE
Nike said revenues for August 31, 2025 ended Q1 were $11.7 billion, up 1% on a reported basis and down 1% on a currency-neutral basis. Net income was $0.7 billion, down 31%, and diluted earnings per share were $0.49, down 30%.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 30, 2025
JBL
Jabil reported net revenue of $8,252 million for Q4 ended August 31, 2025, U.S. GAAP operating income of $337 million, full-year net revenue of $29,802 million and U.S. GAAP operating income of $1,182 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 25, 2025
COST
Costco said net sales for the 16-week Q4 ended August 31 increased 8.0% to $84.4 billion, and net sales for the 52-week fiscal year increased 8.1% to $269.9 billion.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 25, 2025
MU
Micron Technology said revenue for Q4 of fiscal 2025 ended August 28, 2025 was $11.32 billion, compared with $9.30 billion in the prior quarter and $7.75 billion in the same period last year. GAAP net income was $3.20 billion, or $2.83 per diluted share.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 23, 2025
AZO
AutoZone said net sales for the 16 weeks ended August 30, 2025 (Q4) were $6.2 billion, up 0.6% from the prior-year quarter of 17 weeks. Excluding sales from the additional 1 week in the prior-year quarter, adjusted sales increased 6.9%, and total company same store sales rose 4.5% (5.1% on a constant currency basis).
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 23, 2025
MCK
McKesson said it will report financial results across four reportable segments—North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions—commencing in Q2 of fiscal 2026, with its Norwegian operations included in Other.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 18, 2025
GIS
General Mills said net sales for the quarter ended August 24, 2025 were $4.5 billion, down 7%, with a 4-point headwind from the net impact of divestitures and acquisitions; organic net sales were down 3%.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 17, 2025
SNPS
Synopsys said revenue for Q3 of fiscal 2025 was $1.740 billion, up 14% from $1.526 billion in the prior-year quarter, and GAAP net income was $242.5 million, or $1.50 per diluted share.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 9, 2025
ORCL
Oracle said Remaining Performance Obligations for Q1 increased 359% to $455 billion. The company also said it expects Oracle Cloud Infrastructure revenue to grow 77% to $18 billion in the fiscal year.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 9, 2025
CASY
Casey's said net income for the three months ended July 31, 2025 was $215.4 million, up 19.5% from the same period a year ago, diluted earnings per share was $5.77, and EBITDA was $414.3 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 8, 2025
CPRT
Copart said that for the 3 months ended July 31, 2025, it recorded revenue of $1.1 billion, gross profit of $510 million, and net income attributable to Copart, Inc. of $396 million. Revenue increased 5.2% and net income increased 22.9%.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 4, 2025
AVGO
Broadcom said revenue for Q3 of fiscal 2025, ended August 3, 2025, was $15,952 million, up 22% from the prior year period. GAAP net income was $4,140 million and non-GAAP net income was $8,404 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 4, 2025
DLTR
The company said net sales for Q2 of fiscal 2025 ended August 2, 2025 increased 12.3% to $4.6 billion on a continuing operations basis. It said Dollar Tree same-store net sales grew 6.5%, driven by a +3.0% increase in traffic and a +3.4% increase in average ticket.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 3, 2025
CRM
Salesforce said revenue for Q2 2026 (ended July 31) was $10.2 billion, up 10% year-over-year and 9% in constant currency. Subscription and support revenue was $9.7 billion, up 11% and 9% in constant currency.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Sep 3, 2025
ULTA
Ulta Beauty said net sales for the 13 weeks ended August 2, 2025 increased 9.3% to $2,788.5 million from $2,552.1 million in the prior-year period, and comparable sales increased 6.7%.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 28, 2025
MRVL
The company reported that net revenue for the second quarter of fiscal 2026 ended August 2, 2025 was $2.006 billion, up 58% year over year, and GAAP net income was $194.8 million, or $0.22 per diluted share.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 28, 2025
BBY
Best Buy announced enterprise revenue of $9,438 million, comparable sales growth of 1.6% and diluted EPS of $0.87 (adjusted diluted EPS of $1.28) for the 13-week second quarter ended August 2, 2025. Diluted EPS in the prior-year quarter was $1.34.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 28, 2025
NVDA
NVIDIA said revenue for the quarter ended July 27, 2025 was $46.7 billion, up 6% from the previous quarter and up 56% from a year ago. Data Center revenue was $41.1 billion.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 27, 2025
CRWD
CrowdStrike said total revenue for Q2 of fiscal 2026 was $1.17 billion, a 21% increase compared to $963.9 million in the prior-year quarter, and annual recurring revenue as of July 31, 2025 was $4.66 billion, up 20% year-over-year.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 27, 2025
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.